Google
phat stock
Related News
Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032
Phathom surges 125% after FDA grants petition on Voquezna exclusivity
FDA Extends VOQUEZNA Patent Protection: Phathom Secures Decade-Long Market Exclusivity Until 2032
Search Traffic
8 hours ago